Lantern Pharma Inc. — All Filings
230 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
144
3
4
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRSLTR
EFFECT
FWP
PRE 14A
S-1
S-1/A
S-1MEF
S-3
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001213900-21-020952 | Apr 9, 2021 | May 19, 2021 |
| 10-K | ANNUAL REPORT | 0001213900-21-014576 | Mar 10, 2021 | Dec 31, 2020 |
| 8-K | CURRENT REPORT | 0001213900-21-014567 | Mar 10, 2021 | — |
| SC 13G | SC 13G | 0001193125-21-044827 | Feb 16, 2021 | — |
| SC 13G | SC 13G | 0001104659-21-023530 | Feb 16, 2021 | — |
| SC 13G | LANTERN PHARMA INC. | 0000902664-21-000498 | Jan 25, 2021 | — |
| 4 | FORM 4 SUBMISSION | 0000899243-21-002387 | Jan 19, 2021 | Jan 14, 2021 |
| 424B4 | PROSPECTUS SUPPLEMENT | 0001213900-21-002604 | Jan 15, 2021 | — |
| S-1MEF | REGISTRATION STATEMENT | 0001213900-21-002378 | Jan 15, 2021 | — |
| EFFECT | — | 9999999995-21-000165 | Jan 14, 2021 | — |
| CORRESP | — | 0001213900-21-001391 | Jan 11, 2021 | — |
| FWP | FREE WRITING PROSPECTUSES | 0001213900-21-001294 | Jan 11, 2021 | — |
| CORRESP | — | 0001213900-21-001249 | Jan 8, 2021 | — |
| S-1 | REGISTRATION STATEMENT | 0001213900-21-001239 | Jan 8, 2021 | — |
| 8-K | CURRENT REPORT | 0001213900-21-000653 | Jan 6, 2021 | Dec 30, 2020 |
| UPLOAD | — | 0000000000-20-012252 | Dec 21, 2020 | — |
| DRS | — | 0001213900-20-042883 | Dec 16, 2020 | — |
| DRSLTR | — | 0001213900-20-042885 | Dec 15, 2020 | — |
| 10-Q | QUARTERLY REPORT | 0001213900-20-033954 | Oct 29, 2020 | Sep 30, 2020 |
| 8-K | CURRENT REPORT | 0001213900-20-033953 | Oct 29, 2020 | — |
| 8-K | CURRENT REPORT | 0001213900-20-023177 | Aug 21, 2020 | Aug 19, 2020 |
| 8-K | CURRENT REPORT | 0001213900-20-019152 | Jul 30, 2020 | — |
| 10-Q | QUARTERLY REPORT | 0001213900-20-019151 | Jul 30, 2020 | Jun 30, 2020 |
| 8-K | CURRENT REPORT | 0001213900-20-017658 | Jul 16, 2020 | Jul 10, 2020 |
| SC 13D | SC 13D | 0001193125-20-176446 | Jun 23, 2020 | — |
| SC 13D | SCHEDULE 13D | 0001213900-20-015494 | Jun 23, 2020 | — |
| SC 13D | SCHEDULE 13D | 0001213900-20-015351 | Jun 19, 2020 | — |
| 4 | FORM 4 SUBMISSION | 0000899243-20-016898 | Jun 17, 2020 | Jun 15, 2020 |
| 8-K | CURRENT REPORT | 0001213900-20-015132 | Jun 17, 2020 | Jun 11, 2020 |
| 4 | PRIMARY DOCUMENT | 0001789490-20-000005 | Jun 16, 2020 | Jun 15, 2020 |
| 4 | PRIMARY DOCUMENT | 0001813316-20-000002 | Jun 16, 2020 | Jun 15, 2020 |
| SEC STAFF LETTER | — | 9999999997-20-003633 | Jun 16, 2020 | — |
| 4 | — | 0001213900-20-015052 | Jun 15, 2020 | — |
| 4 | — | 0001213900-20-015051 | Jun 15, 2020 | — |
| 4 | — | 0001213900-20-015050 | Jun 15, 2020 | — |
| 4 | — | 0001213900-20-015049 | Jun 15, 2020 | — |
| 4 | — | 0001213900-20-015048 | Jun 15, 2020 | — |
| 4 | — | 0001213900-20-015047 | Jun 15, 2020 | — |
| 4 | — | 0001213900-20-015046 | Jun 15, 2020 | — |
| 4 | OWNERSHIP DOCUMENT | 0001213900-20-015034 | Jun 15, 2020 | — |
| 4 | OWNERSHIP DOCUMENT | 0001213900-20-015029 | Jun 15, 2020 | Jun 11, 2020 |
| 424B4 | PROSPECTUS | 0001213900-20-014754 | Jun 12, 2020 | — |
| S-1MEF | REGISTRATION STATEMENT | 0001213900-20-014750 | Jun 12, 2020 | — |
| EFFECT | — | 9999999995-20-001384 | Jun 10, 2020 | — |
| 3 | PRIMARY DOCUMENT | 0001789490-20-000004 | Jun 10, 2020 | — |
| 3 | PRIMARY DOCUMENT | 0001813316-20-000001 | Jun 10, 2020 | — |
| 3 | FORM 3 SUBMISSION | 0000899243-20-015994 | Jun 10, 2020 | — |
| 3 | OWNERSHIP DOCUMENT | 0001213900-20-014637 | Jun 10, 2020 | — |
| 3 | OWNERSHIP DOCUMENT | 0001213900-20-014635 | Jun 10, 2020 | — |
| 3 | OWNERSHIP DOCUMENT | 0001213900-20-014633 | Jun 10, 2020 | — |